Khaled Dibs1, Austin J Sim2, José A Peñagaricano2, Kujtim Latifi2, Genevieve A Garcia2, Julia A Peters2, Michael L Nieder3, Sungjune Kim2, Timothy J Robinson2,4. 1. Department of Radiation Oncology, The Ohio State University, Columbus OH, United States. 2. Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States. 3. Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States. 4. Department of Biostatistics and Bioinformatics, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States.
Abstract
BACKGROUND: The aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a common part of the conditioning regimen prior to allogeneic stem cell transplantation. Shielding or dose-reduction to the gonads is often desired to preserve fertility, particularly in young patients undergoing transplant for non-malignant indications. Helical tomotherapy (HT) has been shown to be superior to traditional TBI delivery for organ at risk (OA R) doses and dose homogeneity. MATERIALS AND METHODS: We present two representative cases (one male and one female) to illustrate the feasibility of this technique, each of whom received 3Gy in a single fraction prior to allogeneic stem cell transplant for benign indications. The planning target volume (PTV) included the whole body with a subtraction of OA Rs including the lungs, heart, and brain (each contracted by 1cm) as well as the gonads (testicles expanded by 5 cm and ovaries expanded by 0.5 cm). RESULTS: For the male patient we achieved a homogeneity index of 1.35 with a maximum and median planned dose to the testes of 0.53 Gy and 0.35 Gy, respectively. In-vivo dosimetry demonstrated an actual received dose of 0.48 Gy. For the female patient we achieved a homogeneity index of 1.13 with a maximum and median planned dose to the ovaries of 1.66 Gy and 0.86 Gy, respectively. CONCLUSION: Gonadal sparing TBI is feasible and deliverable using HT in patients with non-malignant diseases requiring TBI as part of a pre-stem cell transplant conditioning regimen.
BACKGROUND: The aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a common part of the conditioning regimen prior to allogeneic stem cell transplantation. Shielding or dose-reduction to the gonads is often desired to preserve fertility, particularly in young patients undergoing transplant for non-malignant indications. Helical tomotherapy (HT) has been shown to be superior to traditional TBI delivery for organ at risk (OA R) doses and dose homogeneity. MATERIALS AND METHODS: We present two representative cases (one male and one female) to illustrate the feasibility of this technique, each of whom received 3Gy in a single fraction prior to allogeneic stem cell transplant for benign indications. The planning target volume (PTV) included the whole body with a subtraction of OA Rs including the lungs, heart, and brain (each contracted by 1cm) as well as the gonads (testicles expanded by 5 cm and ovaries expanded by 0.5 cm). RESULTS: For the male patient we achieved a homogeneity index of 1.35 with a maximum and median planned dose to the testes of 0.53 Gy and 0.35 Gy, respectively. In-vivo dosimetry demonstrated an actual received dose of 0.48 Gy. For the female patient we achieved a homogeneity index of 1.13 with a maximum and median planned dose to the ovaries of 1.66 Gy and 0.86 Gy, respectively. CONCLUSION: Gonadal sparing TBI is feasible and deliverable using HT in patients with non-malignant diseases requiring TBI as part of a pre-stem cell transplant conditioning regimen.
Authors: Jeffrey Y C Wong; Andrea Riccardo Filippi; Bouthaina Shbib Dabaja; Joachim Yahalom; Lena Specht Journal: Int J Radiat Oncol Biol Phys Date: 2018-05-02 Impact factor: 7.038
Authors: Martin Borg; Timothy Hughes; Noemi Horvath; Michael Rice; Anthony C Thomas Journal: Int J Radiat Oncol Biol Phys Date: 2002-11-15 Impact factor: 7.038
Authors: J A Peñagarícano; M Chao; F Van Rhee; E G Moros; P M Corry; V Ratanatharathorn Journal: Bone Marrow Transplant Date: 2010-10-11 Impact factor: 5.483
Authors: Sarah J Stephens; Samantha Thomas; David A Rizzieri; Mitchell E Horwitz; Nelson J Chao; Ashley M Engemann; Martha Lassiter; Chris R Kelsey Journal: Adv Radiat Oncol Date: 2016-07-15
Authors: Andreas Springer; Josef Hammer; Erwin Winkler; Christine Track; Roswitha Huppert; Alexandra Böhm; Hedwig Kasparu; Ansgar Weltermann; Gregor Aschauer; Andreas L Petzer; Ernst Putz; Alexander Altenburger; Rainer Gruber; Karin Moser; Karin Wiesauer; Hans Geinitz Journal: Radiat Oncol Date: 2016-03-22 Impact factor: 3.481